Stocklytics Platform
Asset logo for symbol GLSI
Greenwich LifeSciences
GLSI43
$14.50arrow_drop_up8.45%$1.13
Asset logo for symbol GLSI
GLSI43

$14.50

arrow_drop_up8.45%

Income Statement (GLSI)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$2.66M-$2.53M--$2.50M-$1.74M
EBITDA-$2.66M-$2.53M--$2.50M-$1.74M
gross Profit-$903.00-$903.00--$903.00-$903.00
NET Income-$2.60M-$2.47M-$2.74M-$2.39M-$1.62M
total Revenue$0.00$5,418.00$0.00$0.00$0.00

Balance Sheet (GLSI)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$7.22M-$5.50M--$9.14M-$10.94M
stockholders Equity$5.87M$5.12M$6.70M$8.85M$10.64M
total Assets$7.22M$5.51M$6.99M$9.14M$10.95M
total Debt-----
total Liabilities$1.35M$389.61K$294.40K$297.28K$301.54K

Cash Flow (GLSI)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$2.76M$299.11K$0.00$0.00$0.00
free Cash Flow-$1.04M-$1.78M-$2.15M-$1.80M-$966.97K
investing Cash Flow-----
operating Cash Flow-$1.04M-$1.78M-$2.15M-$1.80M-$966.97K

Greenwich LifeSciences (GLSI) Financials

Greenwich LifeSciences, Inc. (GLSI) is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies. In order to assess the financial performance of the company, it is necessary to examine its income statement, balance sheet, and cash flow. The income statement provides a snapshot of the revenue and expenses incurred by GLSI during a specific period of time. It includes key financial metrics such as gross profit, EBIT (Earnings Before Interest and Taxes), EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), and net income from stockholders. These metrics help to evaluate the profitability and operational efficiency of the company. GLSI's total revenue reflects the sum of all sales made during the period.
The balance sheet presents a summary of GLSI's financial position at a specific point in time. It includes information on the company's total assets, total liabilities, and stockholders equity. Total assets represent the value of GLSI's resources, including cash equivalents, investments, property, and intangible assets. Total liabilities encompass the company's debts and obligations. Stockholders equity represents the difference between total assets and total liabilities, reflecting the shareholders' ownership interest in the company. Net debt is a measure of GLSI's financial leverage, calculated as total debt minus cash equivalents. It indicates the company's ability to meet its debt obligations.
Cash flow statement provides insights into GLSI's sources and uses of cash during a specific period. It consists of three sections: operating cash flow, investing cash flow, and financing cash flow. Operating cash flow reflects the cash generated from the company's core operations, including revenue from sales and payments for expenses. Investing cash flow represents the cash used for long-term investments, such as the purchase of property or acquisition of other companies. Financing cash flow reflects the cash sources and uses related to financial activities, such as issuing or repurchasing stock, paying dividends, or obtaining or repaying debt. Free cash flow is a measure of GLSI's cash generation after accounting for capital expenditures necessary to maintain or expand its business.
add Greenwich LifeSciences to watchlist

Keep an eye on Greenwich LifeSciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media